---
figid: PMC8430477__ijms-22-09453-g003
figtitle: 'New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging
  and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK
  Pathway'
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Saccharomyces cerevisiae
- Bos taurus
pmcid: PMC8430477
filename: ijms-22-09453-g003.jpg
figlink: /pmc/articles/PMC8430477/figure/ijms-22-09453-f003/
number: F3
caption: Necroptosis may be a double-edged sword in cancer progression. (a) In the
  CRPC cell line C4-2B, the combination of metformin and simvastatin upregulates RIPK1
  and RIPK3, which further triggers necroptotic cell death. In the breast cancer cell
  line MCF-7, metformin promotes ROS generation and subsequently induces the autophosphorylation
  of RIPK1 at S161, leading to MLKL phosphorylation and necroptosis. (b) Metformin
  induces the AMPK-mediated phosphorylation of Parkin; activated Parkin blocks necroptosis
  and inflammation via the inhibition of RIPK3. This reduces the formation of polyps
  and suppresses the tumorigenesis of CRC.
papertitle: 'New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging
  and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK
  Pathway.'
reftext: Sheng-Kai Hsu, et al. Int J Mol Sci. 2021 Sep;22(17):9453.
year: '2021'
doi: 10.3390/ijms22179453
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: metformin | biguanides | aging | nonapoptotic cell death | metastasis |
  immunosuppression | cancer chemoprevention
automl_pathway: 0.9353096
figid_alias: PMC8430477__F3
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Bos taurus
redirect_from: /figures/PMC8430477__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8430477__ijms-22-09453-g003.html
  '@type': Dataset
  description: Necroptosis may be a double-edged sword in cancer progression. (a)
    In the CRPC cell line C4-2B, the combination of metformin and simvastatin upregulates
    RIPK1 and RIPK3, which further triggers necroptotic cell death. In the breast
    cancer cell line MCF-7, metformin promotes ROS generation and subsequently induces
    the autophosphorylation of RIPK1 at S161, leading to MLKL phosphorylation and
    necroptosis. (b) Metformin induces the AMPK-mediated phosphorylation of Parkin;
    activated Parkin blocks necroptosis and inflammation via the inhibition of RIPK3.
    This reduces the formation of polyps and suppresses the tumorigenesis of CRC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ripk1
  - Ippk
  - Ripk3
  - Mlkl
  - Prkaa2
  - RIPK1
  - RIPK3
  - MLKL
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
---
